These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 28573591)
1. Validation of Protein-Ligand Crystal Structure Models: Small Molecule and Peptide Ligands. Pozharski E; Deller MC; Rupp B Methods Mol Biol; 2017; 1607():611-625. PubMed ID: 28573591 [TBL] [Abstract][Full Text] [Related]
2. Twilight reloaded: the peptide experience. Weichenberger CX; Pozharski E; Rupp B Acta Crystallogr D Struct Biol; 2017 Mar; 73(Pt 3):211-222. PubMed ID: 28291756 [TBL] [Abstract][Full Text] [Related]
3. Tools for ligand validation in Coot. Emsley P Acta Crystallogr D Struct Biol; 2017 Mar; 73(Pt 3):203-210. PubMed ID: 28291755 [TBL] [Abstract][Full Text] [Related]
4. Models of protein-ligand crystal structures: trust, but verify. Deller MC; Rupp B J Comput Aided Mol Des; 2015 Sep; 29(9):817-36. PubMed ID: 25665575 [TBL] [Abstract][Full Text] [Related]
5. Estimation of the protein-ligand interaction energy for model building and validation. Beshnova DA; Pereira J; Lamzin VS Acta Crystallogr D Struct Biol; 2017 Mar; 73(Pt 3):195-202. PubMed ID: 28291754 [TBL] [Abstract][Full Text] [Related]
6. The use of small-molecule structures to complement protein-ligand crystal structures in drug discovery. Groom CR; Cole JC Acta Crystallogr D Struct Biol; 2017 Mar; 73(Pt 3):240-245. PubMed ID: 28291759 [TBL] [Abstract][Full Text] [Related]
7. Experimental free ligand conformations: a missing link in structure-based drug discovery. Chiarparin E; Packer MJ; Wilson DM Future Med Chem; 2019 Jan; 11(2):79-82. PubMed ID: 30648432 [No Abstract] [Full Text] [Related]
8. Stereochemistry and Validation of Macromolecular Structures. Wlodawer A Methods Mol Biol; 2017; 1607():595-610. PubMed ID: 28573590 [TBL] [Abstract][Full Text] [Related]
9. Bridging Crystal Engineering and Drug Discovery by Utilizing Intermolecular Interactions and Molecular Shapes in Crystals. Spackman PR; Yu LJ; Morton CJ; Parker MW; Bond CS; Spackman MA; Jayatilaka D; Thomas SP Angew Chem Int Ed Engl; 2019 Nov; 58(47):16780-16784. PubMed ID: 31385643 [TBL] [Abstract][Full Text] [Related]
10. Ligand fitting with CCP4. Nicholls RA Acta Crystallogr D Struct Biol; 2017 Feb; 73(Pt 2):158-170. PubMed ID: 28177312 [TBL] [Abstract][Full Text] [Related]
11. Biophysical screening for the discovery of small-molecule ligands. Ciulli A Methods Mol Biol; 2013; 1008():357-88. PubMed ID: 23729259 [TBL] [Abstract][Full Text] [Related]
12. Using more than 801 296 small-molecule crystal structures to aid in protein structure refinement and analysis. Cole JC; Giangreco I; Groom CR Acta Crystallogr D Struct Biol; 2017 Mar; 73(Pt 3):234-239. PubMed ID: 28291758 [TBL] [Abstract][Full Text] [Related]
13. Structure Refinement at Atomic Resolution. Jaskolski M Methods Mol Biol; 2017; 1607():549-563. PubMed ID: 28573588 [TBL] [Abstract][Full Text] [Related]
14. Improved ligand geometries in crystallographic refinement using AFITT in PHENIX. Janowski PA; Moriarty NW; Kelley BP; Case DA; York DM; Adams PD; Warren GL Acta Crystallogr D Struct Biol; 2016 Sep; 72(Pt 9):1062-72. PubMed ID: 27599738 [TBL] [Abstract][Full Text] [Related]
15. Fragmentation-tree density representation for crystallographic modelling of bound ligands. Langer GG; Evrard GX; Carolan CG; Lamzin VS J Mol Biol; 2012 Jun; 419(3-4):211-22. PubMed ID: 22446381 [TBL] [Abstract][Full Text] [Related]
16. X-ray free electron laser: opportunities for drug discovery. Cheng RKY; Abela R; Hennig M Essays Biochem; 2017 Nov; 61(5):529-542. PubMed ID: 29118098 [TBL] [Abstract][Full Text] [Related]
17. Techniques, tools and best practices for ligand electron-density analysis and results from their application to deposited crystal structures. Pozharski E; Weichenberger CX; Rupp B Acta Crystallogr D Biol Crystallogr; 2013 Feb; 69(Pt 2):150-67. PubMed ID: 23385452 [TBL] [Abstract][Full Text] [Related]
19. Identification of ligand templates using local structure alignment for structure-based drug design. Lee HS; Im W J Chem Inf Model; 2012 Oct; 52(10):2784-95. PubMed ID: 22978550 [TBL] [Abstract][Full Text] [Related]
20. Molecular recognition of ternary complexes: a new dimension in the structure-guided design of chemical degraders. Hughes SJ; Ciulli A Essays Biochem; 2017 Nov; 61(5):505-516. PubMed ID: 29118097 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]